Navigation Links
Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Date:3/20/2009

TUSTIN, Calif., November 23, 2008 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.

Bavituximab is in clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to $44.4 million with the bioterrorism program of the U.S. Defense Threat Reduction Agency (DTRA). Bavituximab and other anti-PS antibodies are also being studied preclinically in HIV, cytomegalovirus (CMV) and other serious viral infections.

"Based on these findings, anti-PS antibodies such as bavituximab may represent a completely new class of drugs for the treatment of life-threatening viral infections," said study co-author Dr. Philip Thorpe, professor of pharmacology at UT Southwestern Medical Center and a scientific advisor to Peregrine. "By targeting a property of the host cell rather than the virus itself, anti-PS antibodies have the potential to treat a range of viral infections, and they should be less susceptible to the viral mutations that contribute to the development of drug resistance."

In the research reported today, scientists at UT Southwestern assessed the activity of bavituximab in animal models of two lethal viruses--cytomegalovirus and Lassa fever virus, a hemorrhagic fever virus that is listed as a class A bioterrorism agent by the CDC. Bavituximab showed potent anti-viral activity in both models.

Dr. Melina Soares, lead study author and UT Southwestern instructor of pharmacology, commented, "Recent non-affiliated research has further confirmed that exposed PS has immunosuppressive properties and is also clarifying its involvement during vi
'/>"/>

Contact: Barbara Lindheim
blindheim@biocompartners.com
212-918-4650
BioCom Partners
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Nature Reviews Publishes Article About Jennerexs Multi-Mechanistic Cancer Therapeutic
2. Light-speed nanotech: Controlling the nature of graphene
3. Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling
4. Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice
5. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
6. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
7. MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM)
8. Genetic clock makers at UC San Diego publish their timepiece in Nature
9. James L. Wittliff, Ph.D., FACB, to Present Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System at the Association for Molecular Pathology Conference, October 30
10. Natures Premium(R) Brand First Fresh Pork in North America to Carry DNA TraceBack(R) Seal of Authenticity
11. DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 2014 Oramed Pharmaceuticals Inc. (NASDAQCM: ... on the development of oral drug delivery systems, announced ... will present at FireRock Capital,s Micro-Cap Conference. ... ,Date: Tuesday, October 28, 2014 ,Time: 9:15am EST ,Location: ... City , About The FireRock ...
(Date:10/25/2014)... October 24, 2014 Investor-Edge has ... CYTR ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM ... these five companies can be accessed at: http://investor-edge.com/register ... 23, 2014, ended on a positive note as the ...
(Date:10/22/2014)... 2014 New test innovations will be the ... (IVD) test industry, especially as companies struggle with reimbursement ... more than 25 testing innovations in important disease areas ... IVD products. Kalorama details the new approaches its biennial survey ... In Vitro Diagnostic Tests , 9th Edition . ...
(Date:10/22/2014)... The Americas Inorganic Refrigerants Market report defines ... with analysis and forecast of revenue. , Browse ... Market report, to get an idea of the ... of the segmentation in the Americas inorganic refrigerants ... figures. , http://www.micromarketmonitor.com/market/americas-inorganic-refrigerants-4191654241.html , Inorganic ...
Breaking Biology Technology:Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Report: Radical New IVD Test Approaches Key To Growth 2Report: Radical New IVD Test Approaches Key To Growth 3The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor 2The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor 3
... are, important intracellular signals involved in the, ... growth, factors.The discovery of a phosphatidylinositol, ... of, the inositol ring uncovered a new ... signals., Phosphoinositide 3-kinase has been purified to, ...
... and CHT , Ceramic Hydroxyapatite ... Henry Lai, PhD, and Samuel G Franklin, PhD, Bio-Rad Laboratories, Inc., , ... , Introduction , ... using the conventional process composed of a protein A ...
... , Agencourt offers primer walking ... entire plasmid clones. Simply submit your template in either raw or , ... sequence. , Select from either single stranded coverage ... for publication quality or clone validation , purposes. ...
Cached Biology Technology:Purification of Phosphoinositide 3-Kinase With UNO Columns 2Purification of Murine IgG1 Using UNOsphere S and CHT , Ceramic Hydroxyapatite Chromatography, Rev A 2Purification of Murine IgG1 Using UNOsphere S and CHT , Ceramic Hydroxyapatite Chromatography, Rev A 3Purification of Murine IgG1 Using UNOsphere S and CHT , Ceramic Hydroxyapatite Chromatography, Rev A 4Primer Walking 2
(Date:10/25/2014)... Oct.  22, 2014   MedNet Solutions , a ... management systems, is pleased to announce the 2014 ... – to be held in Bloomington, Minnesota ... to have record attendance and promises to be informative, ... The focus of the meeting is iMedNet™ ...
(Date:10/25/2014)... -- This report covers the specifics of microRNA (miRNA) ... pursuit of research due to its versatility and stability, ... RNA components. miRNA,s non-coding nature and ability to affect ... as a biomarker for a variety of diseases. This ... the advancement in therapeutic development. Furthermore there are a ...
(Date:10/25/2014)... , Oct. 22, 2014 A recent ... analysis of the current and future genetic testing market. ... and types are covered in this report. On account ... trends; drivers; and existing strengths and challenges; forecast for ... market is likely to grow at a CAGR of ...
Breaking Biology News(10 mins):MedNet Solutions To Host Third Annual iMedNet User Group Meeting 2MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Genetic Testing Market Outlook 2018 2
... A test for the two strains of human papillomavirus responsible ... molecular assay uses a cervical scraping, like that for a ... 18, responsible for 70 percent of cervical cancers, says Dr. ... Gynecologic Cancer Prevention Center at the Medical College of Georgia. ...
... the world’s 162 species of grouper, a culinary favorite ... with extinction unless proper management or conservation measures are ... Conservation Union (IUCN) as under extinction threat, and the ... of 20 experts from 10 nations determined the extinction ...
... way primitive yeast make cholesterol, a team of ... counterpart controls cholesterol production and potentially drug metabolism. ... Hopkins University School of Medicine, Vanderbilt University, Indiana ... the February issue of Cell Metabolism. ...
Cached Biology News:New test for most virulent HPV strains under study 2New test for most virulent HPV strains under study 3Twenty of world's 162 grouper species threatened with extinction 2Primitive yeast yields secrets of human cholesterol and drug metabolism 2
For microscopy...
... cDNA Synthesis and Labeling Kit generates labeled ... First unmodified cDNA is made via a ... an Oligo(dT) primer. Unlike other methods, there ... the reverse transcription reaction. This unmodified cDNA ...
... high quality microarray scanner based on patented confocal ... spatial resolution. The DNAscope LM is unique ... scanner that is upgradeable to a total of ... Includes control module (computer), monitor, and ...
AC input: 50-60 Hz 115-120 V...
Biology Products: